Your session is about to expire
← Back to Search
Remote functional testing for Low Back Pain
N/A
Waitlist Available
Led By Steve Fischer
Research Sponsored by University of Waterloo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, and average of 1 year
Awards & highlights
Study Summary
This trialis testing a remote functional test to make it easier for injured workers to get the care they need, even in remote areas with less access to clinics.
Eligible Conditions
- Low Back Pain
- Musculoskeletal Injuries
- Shoulder Impingement Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, and average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, and average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Return to work recommendation at discharge
Return to work recommendation at intake
Return to work status
Secondary outcome measures
Adverse events
Client experience and satisfaction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Remote functional testingExperimental Treatment1 Intervention
Clients in this group will complete functional testing using the remote functional testing approach.
Group II: Care-as-usualActive Control1 Intervention
Clients in this group will complete functional testing in the clinic using the care-as-usual approach.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Remote functional testing protocol
2022
N/A
~90
Find a Location
Who is running the clinical trial?
CBI HealthUNKNOWN
1 Previous Clinical Trials
350 Total Patients Enrolled
1 Trials studying Low Back Pain
350 Patients Enrolled for Low Back Pain
University of WaterlooLead Sponsor
125 Previous Clinical Trials
214,268 Total Patients Enrolled
Steve FischerPrincipal InvestigatorAssociate Professor, University of Waterloo
Share this study with friends
Copy Link
Messenger